A fungal drug with dangerous hormone-blocking powers
In short: Ketoconazole was the first oral antifungal medication, treating stubborn skin and systemic infections since 1981. Yet its real impact came from an unintended side effect: at high doses, it blocks testosterone and cortisol production. This property made it a treatment for prostate cancer and excess hair growth—until liver damage forced regulators to severely restrict it.
Ketoconazole emerged from Belgian pharmaceutical research in 1977 and entered medical use four years later, representing a significant breakthrough. Before its arrival, doctors had limited options for treating fungal infections from the inside—earlier medications either worked only on skin or carried severe risks. Ketoconazole disrupted fungal cell membranes by inhibiting ergosterol synthesis, stopping fungi like Candida and Histoplasma cold. It succeeded where other drugs failed, becoming the pharmaceutical standard for serious fungal infections worldwide. By 2023, it had accumulated over 3 million prescriptions annually in the United States alone, ranking as the 140th most prescribed drug in the nation.
The drug's darker properties emerged as doctors understood its mechanism more deeply. At doses exceeding 800 milligrams daily, ketoconazole inhibited multiple human enzymes essential for steroid hormone synthesis, essentially weaponizing the antifungal against the body's own testosterone and cortisol production. Doctors began experimenting with this effect, using it to treat advanced prostate cancer where testosterone fueled tumor growth. The same property proved useful against Cushing's syndrome and female hair loss. However, this hormone-blocking capacity came with catastrophic trade-offs: liver toxicity, adrenal insufficiency, and rare sudden cardiac effects. The FDA issued a severe warning in 2013, declaring the oral form inappropriate for most fungal infections.
The warnings triggered a global retreat. The European Union and Australia withdrew the oral formulation in 2013; China followed in 2015, and use was restricted in the United States and Canada the same year. Newer antifungal agents like fluconazole and itraconazole offered better safety profiles, gradually replacing ketoconazole for routine use. Topical formulations—creams, shampoos, foams applied to skin—proved safe without the organ damage risks, and these remain widely available over the counter. Today, ketoconazole survives as a specialized weapon: topical shampoo for stubborn dandruff, and oral tablets only for rare endemic fungal infections when no alternatives exist. Its story illustrates a recurring pattern in medicine: the most powerful tools often carry the most dangerous side effects.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ketoconazole
To cite this card, link to https://intellectplus.co.uk/app/health-ketoconazole.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
